Blogs about ACOR - Stockpickr! Your Source for Stock Ideas

Blogs about ACOR

Blogs	Description	Date Updated
Tuesday's Upgrades and Downgrades	UPGRADESSonic Solutions (SNIC)- Kaufman Bros Sell » Hold Phase Forward (PFWD)- Needham Hold » Buy Owens-Illinois (OI)- Banc of America Sec Neutral » Buy Wimm-Bill-Dann Foods (WBD)- Credit Suisse Neutral » Outperform JC Penney (JCP)- Deutsche Securities Hold » Buy Cummins (CMI)- UBS Sell » Buy Natl Oilwell Varco (NOV)- RBC Capital Mkts Underperform » Sector Perform VisionChina Media (VISN)- Oppenheimer Perform » Outperform DOWNGRADESPerdigao S.A. (PDA)- ...	June 24, 2008
Analyst downgrades: MOT, MF and ACOR	Filed under: Analyst upgrades and downgrades, Motorola (MOT), Nucor Corp (NUE)MOST NOTEWORTHY: Motorola, MF Global and Acorda Therapeutics were today's noteworthy downgrades: Piper Jaffray downgraded shares of Motorola (NYSE: MOT) to Sell from Neutral after their June channel checks indicated continued market share losses in the company's North American handset business. Keefe Bruyette downgraded shares of MF Global (NYSE: MF) to Market Perform from Outperform on the anticipated di...	June 23, 2008
The week's top biotech gainers	Filed under: Major movement, IndustryThis was quite a week in biotechnology. You had a major premium buyout and had much data come out from the American Society of Clinical Oncology (ASCO) and others. This is far from all of the movers, but it is a brief summary of the major gainers from BioHealthInvestor.com showing how large some moves were in biotechnology this week. Acorda Therapeutics Inc. (NASDAQ: ACOR) had a great week after it announced positive data from a second Phase III study of its...	June 06, 2008
Pre-Market Volume Spike: Acorda Therapeutics (ACOR)	Acorda Therapeutics (NASDAQ: ACOR) is seeing shares surge on active pre-market trading volume on news this Monday morning. The company announced positive data from a second Phase III study of its Fampridine-SR as a treatment for patients’ walking abilities who suffer from multiple sclerosis. Acorda trades has an average daily volume of about about 570,000 shares per day, and it has already seen 345,000 shares trade as of 8:25 AM EST. It closed at $21.56 on Friday and shares are north o...	June 02, 2008
Acorda Therapeutics (ACOR) CEO Adopts Stock Trading Plan	Visit StreetInsider.com at http://www.streetinsider.com/Insider+Trades/Acorda+Therapeutics+%28ACOR%29+CEO+Adopts+Stock+Trading+Plan/3474751.html for the full story....	March 19, 2008
Analyst initiations: Chipotle Mexican Grill, Micrus Endovascular, Acorda Therapeutics	Filed under: Analyst reports, Chipotle Mexican Grill'A' (CMG), Analyst initiationsMOST NOTEWORTHY: Chipotle Mexican Grill, Micrus Endovascular and Acorda Therapeutics were today's noteworthy initiations: Jefferies expects the quality gap between Chipotle Mexican Grill (NYSE: CMG) and its peers will become more apparent in a weakening consumer environment. The firm started shares with a Buy rating and $110 target. Micrus Endovascular (NASDAQ: MEND) was initiated with an Outperform ra...	March 12, 2008
Analyst initiations: PRSP, MVO and BRLI	Filed under: Analyst initiationsMOST NOTEWORTHY: Properity Bancshares, MV Oil Trust and Bio-Reference Lab were today's noteworthy initiations: B. Riley initiated Prosperity Bancshares (NASDAQ:PRSP) with a Buy rating and $32 target. The firm thinks the company's lower risk profile is supported by its conservative management team and by the relative strength of the Texas economy and housing markets. Oppenheimer assumed MV Oil Trust (NYSE:MVO) with a Perform rating and believes the com...	February 21, 2008
The Day In Biotech Stocks (January 28, 2008) (ACOR, BIIB, CELG, PHRM, CRXX, LIPD, MDVN, PCOP)	Acorda Therapeutics inc. (NASDAQ: ACOR) showed late stage trial results on its drug candidate Fampridine-SR for treating multiple sclerosis. This data showed... [[ This is a content summary only. Visit my website for full links, other content, and more! ]] ...	January 28, 2008
Pre-Market Stock News (July 20, 2007)	(ACOR) Acorda COO resigned to pursue other interests.(AMD) Advanced Micro Devices traded up 4% after revenues were ahead of plan on processor sales.(AUY) Yamana Gold makes business combination offer for Meridian Gold.(BVF) Biovail received a non-approval letter from the U.S. FDA for its NDA for BVF-033.(C) Citigroup $1.24 EPS vs $1.13 estimate, Revenues $25.6 Billion vs. $24.88B est.(CAT) Caterpillar $1.24 EPS vs $1.49 estimate.(ERIC) Ericsson ADR’s trading down over 4% after earnings rose 12%...	July 20, 2007
Pre-Market Stock News (June 8, 2007)	(ACOR) Acordia Therapeutics priced 3.75 million shares in a secondary at $18.50 per share.(BAGL) Einstein Noah Restaurant Group, Inc. sold 5 million shares at$18.00 per share; this was NWRG-PinkSheets as New World Restaurant Group.(BRCM) Broadcom won part of the patent case against Qualcomm.(EPIQ) EPIQ Systems trades ex-split today to reflect a 3-2 stock split.(FTEK) Fuel-Tech won first order for its targeted corrosion inhibition technology.(GRRF) China Grentech won bids for new trial orders fro...	June 08, 2007

Enter search text here: